Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Polydactyly-myopia syndrome is an exceedingly rare autosomal dominant developmental anomaly reported in 1986 in nine individuals among four generations of the same family. The syndrome is characterized clinically by four-limb postaxial polydactyly and progressive myopia. There have been no further descriptions in the literature since 1986.
Features include: Postaxial hand polydactyly and Myopia.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Arms and legs | 1 | Postaxial hand polydactyly |
Biomarker and diagnostic research for polydactyly-myopia syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for polydactyly-myopia syndrome.
123 publications have been identified in PubMed for polydactyly-myopia syndrome. Research spans Review / Meta-Analysis (71%), Basic Science / Preclinical (15%), and Case Report / Case Series (5%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 87 | 71% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 8:40 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
18 |
15% |
Patient case studies | 6 | 5% |
Disease patterns and progression | 6 | 5% |
Other research | 3 | 2% |
Clinical study results | 2 | 2% |
Testing and diagnosis research | 1 | 1% |
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Ann Allergy Asthma Immunol*. [Review / Meta-Analysis]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Basic Science / Preclinical]
Papazachariou A (2026). [PMID: 41128447](https://pubmed.ncbi.nlm.nih.gov/41128447/). *Curr Opin Clin Nutr Metab Care*. [Review / Meta-Analysis]
Buel KL (2026). [PMID: 41569909](https://pubmed.ncbi.nlm.nih.gov/41569909/). *FP Essent*. [Review / Meta-Analysis]
Burnett BA (2025). [PMID: 40983242](https://pubmed.ncbi.nlm.nih.gov/40983242/). *Am J Obstet Gynecol MFM*. [Basic Science / Preclinical]
Karuntu JS (2025). [PMID: 39733931](https://pubmed.ncbi.nlm.nih.gov/39733931/). *Prog Retin Eye Res*. [Review / Meta-Analysis]
Sakuma H (2025). [PMID: 39143740](https://pubmed.ncbi.nlm.nih.gov/39143740/). *Dev Med Child Neurol*. [Review / Meta-Analysis]
Pena C (2025). [PMID: 40146047](https://pubmed.ncbi.nlm.nih.gov/40146047/). *Minerva Med*. [Review / Meta-Analysis]
Bowe S (2025). [PMID: 40451572](https://pubmed.ncbi.nlm.nih.gov/40451572/). *Presse Med*. [Review / Meta-Analysis]
Gunn NA (2025). [PMID: 40286453](https://pubmed.ncbi.nlm.nih.gov/40286453/). *Thromb Res*. [Review / Meta-Analysis]